Institution identification

PURI

https://redirect.ema.europa.eu/resource/3331423

Institution ID

3331423

Institution full name and acronym

Hospital La Paz

ENCePP partner

No
Institution details
Experience with collecting data directly from individual patients or respondents:
No
Interest in carrying out research that is funded by pharmaceutical companies:
No

Studies conducted by the institution

ACUTE AND CHRONIC ACETAMINOPHEN OVERDOSE IN PEDIATRIC POPULATION: PROSPECTIVE STUDY OF COHORT TO EVALUATE CLINIC FACTORS AND BIOMARKERS TO PREDICT DEVELOPMENT OF HEPATOTOXICITY/SOBREDOSIS AGUDA Y CRÓNICA DE PARACETAMOL EN POBLACIÓN PEDIÁTRICA: ESTUDIO PROSPECTIVO DE COHORTES PARA EVALUAR LOS FACTORES CLINICOS Y BIOMARCADORES PREDICTORES DE HEPATOTOXICIDAD (GEIPA-2012-01)
Alofisel-5003: An Observational Post-Marketing Registry on the Effectiveness and Safety of Darvadstrocel in Patients With Crohn's Disease and Complex Perianal Fistulas (INSPIRE)
CASE AND CONTROLS NESTED IN AN AMBISPECTIVE COHORT TO EVALUATE THE EFFECT OF CO-MEDICATION ON THE EVOLUTION OF SARS-CoV-2 CORONAVIRUS INFECTION (COVID-19) (HULP-COVID19-ACE2-20)
FOUR-YEAR EFFECTIVENESS OF COVID-19 VACCINES AGAINST SEVERE DISEASE AND ASYMPTOMATIC INFECTION: THE COVIDVAC@SPAIN STUDY
Risk of lactic acidosis associated with metformin use in patients with type 2 diabetes and moderate-severe chronic kidney disease: a case-control study (ALIMAR-C2)